Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats

Clinical Immunology

Volumn 90, Issue 1, 1999, Pages 119-127

  Lu, Shemin ^a   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Collagen II; Collagen IX; Collagen induced arthritis; Nasal tolerance; Pristane induced arthritis

Indexed keywords

COLLAGEN TYPE 2; COLLAGEN TYPE 9; PRISTANE; VACCINE;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VACCINATION;

EID: 0032931041     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4615     Document Type: Article

References (34)

1. Jawaheer D., Thomson W., MacGregor A. J., Carthy D., Davidson J., Dyer P. A., Silman A. J., Ollier W. E. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum. 37:1994;681-686.
2. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 261:1993;1727-1730.
3. Sieper J., Kary S., Sorensen H., Alten R., Eggens U., Huge W., Hiepe F., Kuhne A., Listing J., Ulbrich N., Braun J., Zink A., Mitchison N. A. Oral type II collagen treatment in early rheumatoid arthritis. Arthritis Rheum. 39:1996;41-51.
4. Barnett M. L., Kremer J. M., St. Clair E. W., Clegg D. O., Furst D., Weisman M., Fletcher M. J., Chasan-Taber S., Finger E., Morales A., Le C. H., Trentham D. E. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 41:1998;290-297.
5. Thompson H. S., Staines N. A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64:1986;581-586.
6. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA. 83:1986;7443-7446.
7. Zhang Z. J., Lee C. S. Y., Lider O., Weiner H. L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145:1990;2489-2493.
8. Yoshino S., Quattrocchi E., Weiner H. L. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum. 38:1995;1092-1096.
9. Miller A., Lider O., Weiner H. L. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:1991;791-798.
10. al-Sabbagh A., Miller A., Santos L. M., Weiner H. L. Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24:1994;2104-2109.
11. Blanas E., Carbone F. R., Allison J., Miller J. F., Heath W. R. Induction of autoimmune diabetes by oral administration of autoantigen. Science. 274:1996;1707-1709.
12. Genain C. P., Abel K., Belmar N., Villinger F., Rosenberg D. P., Linington C., Raine C. S., Hauser S. L. Late complications of immune deviation therapy in a nonhuman primate. Science. 274:1996;2054-2057.
13. Dick A. D., Cheng Y. F., McKinnon A., Liversidge J., Forrester J. V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br. J. Ophthalmol. 77:1993;171-175.
14. Staines N. A., Harper N., Ward F. J., Malmstrom V., Holmdahl R., Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103:1996;368-375.
15. Vingsbo C., Sahlstrand P., Brun J. G., Jonsson R., Saxne T., Holmdahl R. Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149:1996;1675-1683.
16. Holmdahl R., Vingsbo C., Hedrich H., Karlsson M., Kvick C., Goldschmidt T. J., Gustafsson K. Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules. Eur. J. Immunol. 22:1992;419-424.
17. Goldschmidt T. J., Andersson M., Malmström V., Holmdahl R. Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis. Immunobiology. 184:1992;359-371.
18. Smith B. D., Martin G. R., Miller E. J., Dorfman A., Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch. Biochem. Biophys. 166:1975;181-186.
19. Miller E. J., Rhodes R. K. Preparation and characterization of the different types of collagen. Methods Enzymol. 82:1982;33-64.
20. t'Hart B. A., Kraakman E., Jonker M. An ear swelling reaction for in vivo monitoring of inflammatory T cell activity in collagen-arthritic rats. J. Immunol. Methods. 176:1994;179-184.
21. Holmdahl R., Klareskog L., Andersson M., Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics. 24:1986;84-89.
22. Terato K., Ye X. J., Miyahara H., Cremer M. A., Griffiths M. M. Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen andEscherichia coli. Br. J. Rheumatol. 35:1996;828-838.
23. al-Sabbagh A., Nelson P. A., Akselband Y., Sobel R. A., Weiner H. L. Antigen-driven peripheral immune tolerance: Suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell Immunol. 171:1996;111-119.
24. Karpus W. J., Kennedy K. J., Smith W. S., Miller S. D. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. J. Neurosci. Res. 45:1996;410-423.
25. Thompson H. S., Harper N., Bevan D. J., Staines N. A. Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity. 16:1993;189-199.
26. Weiner H. L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
27. Greenbury C. L., Skingle J. Anti-cartilage antibody. J. Clin. Pathol. 32:1979;826-831.
28. Londei M., Savill C. M., Verhoef A., Brennan F., Leech Z. A., Duance V., Maini R. N., Feldmann M. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 86:1989;636-640.
29. Tarkowski A., Klareskog L., Carlsten H., Herberts P., Koopman W. J. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 32:1989;1087-1092.
30. Cook A. D., Rowley M. J., Mackay I. R., Gough A., Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 39:1996;1720-1727.
31. Rönnelid J., Lysholm J., Engström-Laurent A., Klareskog L., Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 37:1994;1023-1029.
32. Fugger L., Rothbard J. B., Sonderstrup-McDevitt G. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur. J. Immunol. 26:1996;928-933.
33. Rosloniec E. F., Brand D. D., Myers L. K., Whittington K. B., Gumanovskaya M., Zaller D. M., Woods A., Altmann D. M., Stuart J. M., Kang A. H. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J. Exp. Med. 185:1997;1113-1122.
34. Andersson E. C., Hansen B. E., Jacobsen H., Madsen L. S., Andersen C. B., Engberg J., Rothbard J. B., McDevitt G. S., Malmstrom V., Holmdahl R., Svejgaard A., Fugger L. Definition of MHC and T cell receptor contacts in the HLA-DR4-restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sci. USA. 95:1998;7574-7579.